X-102714234-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001004051.4(GPRASP2):c.-366A>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.114 in 111,396 control chromosomes in the GnomAD database, including 658 homozygotes. There are 3,612 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.11 ( 657 hom., 3607 hem., cov: 23)
Exomes 𝑓: 0.055 ( 1 hom. 5 hem. )
Consequence
GPRASP2
NM_001004051.4 5_prime_UTR
NM_001004051.4 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0490
Genes affected
GPRASP2 (HGNC:25169): (G protein-coupled receptor associated sorting protein 2) The protein encoded by this gene is a member of a family that regulates the activity of G protein-coupled receptors (GPCRs). The encoded protein has been shown to be capable of interacting with several GPCRs, including the M1 muscarinic acetylcholine receptor and the calcitonin receptor. Several transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, May 2010]
ARMCX5-GPRASP2 (HGNC:42000): (ARMCX5-GPRASP2 readthrough) This locus represents naturally occurring readthrough transcription among the adjacent armadillo repeat containing, X-linked 5 (ARMCX5), G protein-coupled receptor associated sorting proteins 1 and 2 (GPRASP1 and GPRASP2), basic helix-loop-helix family member b9 (BHLHB9), and long intergenic non-protein coding RNA 630 (LINC00630) genes on chromosome X. Transcripts may make use of multiple alternative promoters and polyadenylation signals in this region. Readthrough transcripts may produce proteins identical to the proteins encoded by GPRASP2 or BHLHB9. [provided by RefSeq, Apr 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant X-102714234-A-G is Benign according to our data. Variant chrX-102714234-A-G is described in ClinVar as [Benign]. Clinvar id is 1226940.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.2 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GPRASP2 | NM_001004051.4 | c.-366A>G | 5_prime_UTR_variant | 4/5 | ENST00000483720.7 | ||
ARMCX5-GPRASP2 | NR_146584.3 | n.763A>G | non_coding_transcript_exon_variant | 6/19 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GPRASP2 | ENST00000483720.7 | c.-366A>G | 5_prime_UTR_variant | 4/5 | 2 | NM_001004051.4 | P1 | ||
ARMCX5-GPRASP2 | ENST00000652409.1 | c.-788A>G | 5_prime_UTR_variant | 4/8 | P1 |
Frequencies
GnomAD3 genomes AF: 0.114 AC: 12672AN: 111032Hom.: 655 Cov.: 23 AF XY: 0.108 AC XY: 3605AN XY: 33286
GnomAD3 genomes
AF:
AC:
12672
AN:
111032
Hom.:
Cov.:
23
AF XY:
AC XY:
3605
AN XY:
33286
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0548 AC: 17AN: 310Hom.: 1 Cov.: 0 AF XY: 0.0595 AC XY: 5AN XY: 84
GnomAD4 exome
AF:
AC:
17
AN:
310
Hom.:
Cov.:
0
AF XY:
AC XY:
5
AN XY:
84
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.114 AC: 12680AN: 111086Hom.: 657 Cov.: 23 AF XY: 0.108 AC XY: 3607AN XY: 33350
GnomAD4 genome
AF:
AC:
12680
AN:
111086
Hom.:
Cov.:
23
AF XY:
AC XY:
3607
AN XY:
33350
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 12, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at